




































Growing evidence supports the view that the functional 
state of mitochondria within eukaryotic cells has a 
major impact on cellular and organismal aging [1-4]. 
An age-related progressive decline in mitochondrial 
function is therefore considered to be one of the cellular 
and molecular hallmarks of aging in eukaryotic 
organisms across phyla [5]. Mitochondria play a key 
role in the aging process because these organelles (i) 
supply the eukaryotic cell with the bulk of ATP, which 
is synthesized via oxidative phosphorylation coupled to 
the electron transport chain in the inner mitochondrial 
membrane (IMM) [1, 6, 7]; (ii) generate (mainly as by-
products of mitochondrial respiration) and release 
reactive oxygen species (ROS) known for their critical 
role in the development of a pro- or anti-aging cellular 
pattern   [8-13];  and  (iii)  produce  and  release  diverse  
 
 



































metabolites, iron-sulfur clusters (ISC), proteins, 
peptides and DNA fragments that in cellular locations 
outside mitochondria trigger cascades of events 
essential for establishing the rate of cellular aging (for a 
recent comprehensive review see ref. [4]). 
 
The maintenance of a healthy population of functional 
mitochondria capable of effectively performing all these 
longevity-defining processes critically depends on the 
sustainable biogenesis of these organelles. 
Mitochondrial biogenesis involves the replication and 
transcription of mitochondrial DNA (mtDNA), the 
synthesis of proteins encoded by mtDNA, the import 
and processing of proteins encoded by nuclear DNA 
and synthesized in the cytosol, the assembly of 
respiratory protein complexes and supercomplexes 
within the IMM, the synthesis and remodeling of 
mitochondrial membrane glycerophospholipids in the 



























our  findings suggest a mechanism underlying the ability of LCA to delay chronological aging  in yeast by accumulating  in
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IMM, and a bidirectional movement of 
glycerophospholipids via zones of close apposition 
between the outer mitochondrial membrane (OMM) and 
the mitochondria-associated membrane (MAM) domain 
of the endoplasmic reticulum (ER) [6, 14-23]. 
Moreover, the preservation of a healthy population of 
functional mitochondria competent at performing the 
abovementioned three types of longevity-defining 
processes is under stringent surveillance by an intricate 
network of mitochondrial quality control pathways. 
These pathways include: (i) the repair of mtDNA; (ii) 
the proper folding and proteolytic processing of newly 
imported mitochondrial proteins; (iii) the repair and 
refolding of unfolded and misfolded mitochondrial 
proteins; (iv) the degradation of irreversibly damaged 
proteins within mitochondria; (v) the global hyper-
acetylation of mitochondrial proteins; (vi) deacetylation, 
demalonylation, desuccinylation  and hyperoxidation of 
some mitochondrial proteins; (vii) the mitochondrial 
retrograde signaling, back-signaling and unfolded 
protein response pathways of mitochondria-to-nucleus 
communications; (viii) mitochondrial fusion and 
fission; (ix) the contact-dependent and -independent 
communications of mitochondria with other cellular 
organelles; and (x) mitophagy, a process responsible for 
the selective macroautophagic degradation of aged, 
dysfunctional, damaged or excessive mitochondria [4, 
24-37]. 
 
A body of recent evidence supports the notion that the 
competence of mitochondria at performing the 
aforementioned three types of longevity-defining 
processes early in life of an eukaryotic organism or in a 
replicatively and chronologically “young” eukaryotic 
cell defines the long-term viability of the organism and 
the cell and, thus, is critical for regulating organismal 
longevity and cellular aging [9, 11, 13, 38-50]. Indeed, 
studies in the nematode Caenorhabditis elegans 
revealed that the efficacies of mitochondrial respiration, 
membrane potential and ATP production during larval 
development are under rigorous surveillance by a 
regulatory system that operates as a rheostat modulating 
the extent of gene expression activation by UBL-5 and 
DVE-1 [38, 40, 43, 45]. These two transcription factors 
in the nucleus trigger an anti-aging transcriptional 
program that is aimed at sustaining high levels of 
certain proteins known for their essential roles in 
extending organismal longevity [46]. Thus, the 
efficacies of mitochondrial respiration, membrane 
potential and ATP production early in life of the 
nematode define the rate of cellular and organismal 
aging that persists during adulthood. Moreover, studies 
in yeast demonstrated that caloric restriction (CR) and 
rapamycin, the potent dietary and pharmacological anti-
aging interventions (respectively), increase mito-
chondrial respiration, membrane potential and ROS 
production in chronologically “young” cells [9, 13, 39, 
41, 42, 47]. In turn, these changes in the functional state 
of mitochondria alter the efficiencies of several 
longevity-defining cellular processes in chronologically 
“old” cells, thereby ultimately extending their longevity 
[9, 11, 13, 39, 41, 42, 47, 50-52]. 
 
The functional state of mitochondria is an important 
therapeutic target for pharmacological interventions. 
The numerous small molecules that are used for so-
called “mitochondrial pharmacology” modulate various 
mitochondria-confined processes. These small 
molecules act (i) directly, following their delivery to the 
mitochondrial matrix, the IMM or the OMM; or (ii) 
indirectly, by binding to and altering activities of 
transcription factors for nuclear genes encoding various 
mitochondrial proteins [34, 53-61]. One of these small 
molecules, a plastoquinone derivate SkQ1, has been 
shown to exhibit the profound longevity-extending 
effects in evolutionarily distant organisms and to 
improve overall health by delaying the onset of various 
age-related diseases [62-67]. After being specifically 
targeted to the matrix-facing leaflet of the IMM, SkQ1 
acts as a rechargeable antioxidant that protects 
membrane proteins and glycerophospholipids against 
oxidative damage [63, 64]. 
           
We recently identified lithocholic acid (LCA), a bile 
acid, as a natural compound that acts synergistically 
with CR to cause a substantial increase in yeast 
chronological lifespan under longevity-extending CR 
conditions [44]. In this study we examined a mechanism 
underlying the potent anti-aging effect of LCA in yeast 
cultured under CR. Our findings provide evidence that 
(i) exogenously added LCA enters yeast cells; (ii) 
intracellular LCA accumulates in mitochondria, where 
it associates mainly with the IMM, and also resides in 
the OMM; (iii) by eliciting a remodeling of 
glycerophospholipid synthesis and movement within 
both mitochondrial membranes, LCA causes significant 
age-related changes in the membrane lipidome of 
mitochondria and alters their size, number and 
morphology; (iv) the LCA-driven changes in the 
membrane lipidome and morphology of mitochondria 
alter the age-related dynamics of mitochondrial 
respiration, membrane potential, ATP synthesis and 
ROS homeostasis; and (v) the triggered by LCA 
changes in the age-related chronology of these vital 
mitochondrial processes extend yeast chronological 
lifespan. Based on these findings, we propose a model 
for a mechanism underlying the ability of LCA to delay 
chronological aging in yeast by accumulating in the 
IMM and OMM, altering the metabolomes of both 
mitochondrial membranes, and affecting mitochondrial 
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morphology and function. The central tenet of this 
model is that mitochondrial membrane lipidome plays 




LCA enters yeast cells 
 
In the high-throughput screen that led to the 
identification of LCA as an anti-aging molecule, all of 
the tested chemical compounds derived from several 
commercial libraries were dissolved in dimethyl 










































solvent in yeast cultures was 1% (v/v) [44]. Due to the 
well-known ability of DMSO to create pores in the 
hydrophobic core of a membrane bilayer and to increase 
its fluidity, this amphiphilic enhancer of cell membrane 
permeability for drugs and DNA is traditionally used as 
a vehicle for delivering various chemical compounds 
into a cell [68]. If LCA was first dissolved in DMSO 
and then added to growth medium at a final 
concentration of 50 µM immediately following cell 
inoculation into the medium, this bile acid significantly 
extended the chronological lifespan (CLS) of yeast cells 
that were cultured under caloric restriction (CR) 












































Figure  1.  In  yeast  cultured  with
exogenously  added  LCA  in  the
presence  or  absence  of  DMSO,  this
bile acid enters cells and accumulates
in  a  subcellular  fraction  consisting  of
mitochondria, ER, Golgi, vacuoles, PM
and nuclei.  (A and B) Cells were cultured
in  the  nutrient‐rich  YP  medium  initially
containing 0.2% glucose with 50 µM LCA or
without it, in the presence of 1% DMSO (A)
or  in  its  absence  (B).  Survival  curves  of
chronologically  aging  yeast  are  shown;
data  are  presented  as means  ±  SEM  (n  =
11‐14). (C and D) The age‐related dynamics
of changes  in  the  levels of LCA associated
with  cells  or  remaining  in  the  cultural
medium  in  yeast  cultures  that  were
incubated with exogenously added 50 µM
LCA  in the presence of 1% DMSO (C) or  in
its  absence  (D);  data  are  presented  as
means ± SEM (n = 5‐6). (E and F) The age‐
related  dynamics  of  changes  in  the  levels
of  LCA  recovered  in  various  subcellular
fractions  that  were  separated  by
differential  centrifugation  of  yeast  cell
homogenates;  data  for  subcellular
fractions  recovered  from  yeast  cultures
that  were  incubated  with  exogenously
added 50 µM LCA in the presence of DMSO
(E)  or  in  its  absence  (F)  are  presented  as
means  ±  SEM  (n  =  4).  The  efficacy  of
spheroplast  formation  is  also  shown  as
means  ±  SEM  (n  =  4).  (G)  Outline  of  a
procedure  for  subcellular  fractionation  of
yeast cell homogenates through sequential
centrifugation  steps  of  increasing  force
and  duration.  Abbreviations:  Diauxic  (D),
logarithmic  (L),  post‐diauxic  (PD)  or
stationary (ST) growth phase. 
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Noteworthy, LCA at a final concentration of 50 µM 
displayed a similar strong beneficial effect on the CLS 
of yeast cells cultured under CR at 0.2% glucose if it 
was added to growth medium in water, i.e., under 
conditions that are unlikely to enhance cell membrane 
permeability for exogenous chemical compounds 
(Figure 1B; [37]). This observation suggested that, akin 
to the established mechanism underlying an anti-tumor 
effect of LCA in cultured human cells [69], a 
mechanism by which this bile acid extends longevity of 
chronologically aging yeast under CR conditions does 
not involve its delivery into cells. As a first step towards 
addressing this important spatial aspect of the 
longevity-extending effect of exogenously added LCA, 
we used a quantitative mass spectrometric analysis to 
compare the relative level of cell-associated LCA to that 
of LCA in the cultural medium. Our analysis of the age-
related dynamics of changes in the levels of LCA 
associated with cells or remaining in the cultural 
medium revealed that in yeast cultures incubated with 
exogenously added 50 µM LCA in the presence of 
DMSO, only a minor portion of this bile acid (from 
6.1% to 14.6% at different periods of chronological 
lifespan) was present in a cell-associated form (Figure 
1C). In contrast, in yeast cultures incubated with 
exogenously added 50 µM LCA in the absence of 
DMSO, the major portion of this bile acid (from 76.7% 
to 94.8%, depending on a period of chronological 
lifespan) was associated with cells (Figure 1D). 
 
We then used subcellular fractionation by differential 
centrifugation (Figure 1G) followed by mass 
spectrometric quantitation of LCA to assess its relative 
levels in various subcellular fractions. We found that in 
yeast cultured with exogenously added LCA in the 
presence of DMSO (i) LCA was present mostly (from 
71.3% to 90.2%, depending on a period of 
chronological lifespan) in the cytosolic (100KgS) 
fraction; (ii) from 5.2% to 21.6% of LCA was recovered 
in the 12KgP fraction containing mitochondria, 
endoplasmic reticulum (ER), Golgi, vacuoles, plasma 
membrane (PM) and nuclei; and (iii) from 4.2% to 7.1% 
of LCA was associated with cell surface, as it was 
recovered in the 1KgP fraction known to consist of 
unspheroplasted cells and cell debris (Figure 1E). In 
contrast, in yeast cultured with exogenously added LCA 
in the absence of DMSO (i) LCA was mostly (from 
73.3% to 92.2%) associated with cell surface (1KgP 
fraction); (ii) from 4.1% to 23.6% of LCA was 
recovered in the 12KgP fraction consisting of 
mitochondria, ER, Golgi, vacuoles, PM and nuclei; and 
(iii) only a minor portion (from 2.9% to 4.4%) of LCA 
was present in the cytosolic (100KgS) fraction (Figure 
1F). 
 
In sum, our quantitative analysis of LCA recovered in 
various subcellular fractions separated by differential 
centrifugation implies that in yeast cultured with 
exogenously added LCA in the presence of DMSO, this 
bile acid is evenly distributed between the cultural 
medium and the cytosol – perhaps because of its high 
solubility in DMSO present in the cultural medium and 
the cytosol and probably due to its passive diffusion 
through pores in the PM created by DMSO. 
Importantly, in yeast cultured with LCA in the presence 
of DMSO, up to 21.6% of the intracellular pool of this 
bile acid is confined to the 12KgP fraction containing 
mitochondria, ER, Golgi, vacuoles, PM and nuclei. 
Furthermore, in yeast cultured with exogenously added 
LCA in the absence of DMSO, this most hydrophobic 
molecular form of bile acids [44] associates mainly with 
cell surface – possibly because of its low solubility in 
water leading to its adhesion to the cell wall and 
perhaps due to lack of pores in the PM. Yet, even in 
yeast cultured with LCA in the absence of DMSO, up to 
28% of this bile acid enters yeast cells and associates 
mainly with the 12KgP fraction consisting of 
mitochondria, ER, Golgi, vacuoles, PM and nuclei. 
 
Intracellular LCA accumulates in mitochondria 
 
To elucidate in which organelle or organelles present 
in the 12KgP subcellular fraction LCA resides, we 
subjected the mix of mitochondria, ER, Golgi, 
vacuoles, PM and nuclei recovered in this organellar 
fraction to separation by centrifugation to equilibrium 
in a sucrose density gradient. The shape of this 
gradient has been previously optimized for the 
purification of mitochondria devoid of contamination 
by other organelles present in the 12KgP fraction 
(Figure 2; [70]). Our mass spectrometric identification 
and quantitation of LCA in gradient fractions revealed 
that the 12KgP-associated pool of LCA is almost 
exclusively confined to mitochondria of yeast cultured 
with this bile acid in the presence of DMSO (Figures 
2A and 2B) or in its absence (Figures 2C and 2D). We 
therefore concluded that, regardless of the presence of 
DMSO in yeast cultures containing exogenously added 
LCA, the only kind of cellular organelle this 
longevity-extending bile acid accumulates in is the 
mitochondrion. 
 
Mitochondria-associated LCA resides mainly in the 
inner mitochondrial membrane (IMM) 
 
To examine in which mitochondrial sub-compartment 
LCA resides, we first subjected purified mitochondria to 
fractionation using a swell-shrink procedure and 
subsequent equilibrium density gradient centrifugation. 
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This fractionation approach enables to separate 
mitochondria into the intact outer mitochondrial 
membrane (OMM) fraction, the intact intermembrane 
space (IMS) fraction and the mitoplast fraction 
consisting of mitochondrial matrix surrounded by the 
intact IMM [71]. We found that, regardless of the 
presence of DMSO in yeast cultures containing 
















































acid (from 69.5% to 74.6% of the total pool of 
mitochondria-associated LCA) were confined to 
mitoplasts (Figures 3A and 3B). A smaller portion of 
LCA (from 20.7% to 26.6% of the total pool of 
mitochondrial LCA) was recovered in the OMM, and 
only minute quantities of it (from 1.4% to 8.3% of the 
total pool of mitochondria-associated LCA) were found 
















































Figure 2.  Intracellular  LCA accumulates  in mitochondria. Cells were  cultured  in  the nutrient‐rich  YP medium  initially
containing 0.2% glucose with exogenously added 50 µM LCA in the presence of 1% DMSO (A and B) or in its absence (C and D).
Homogenates  of  cells  that were  taken  at  day  4  (A  and  C)  or  7  (B  and  D)  of  cell  culturing were  subjected  to  subcellular
fractionation to recover a mix of mitochondria, endoplasmic reticulum (ER), Golgi, vacuoles, plasma membrane (PM) and nuclei
in a 12,000 × g pellet. The recovered mix of organelles was fractionated using centrifugation to equilibrium in a sucrose density
gradient.  The  percent  recoveries  of  loaded  protein  and  LCA  in  sucrose  gradient  fractions  are  presented.  Equal  volumes  of
gradient fractions were subjected to  lipid extraction followed by mass spectrometric  identification and quantitation of LCA  in
the extracts of  lipids. Equal volumes of gradient  fractions were also analyzed by  immunoblotting with antibodies to Por1p  (a
protein marker of mitochondria), Nsp1p  (a protein marker of  the nucleus), Dpm1p  (a protein marker of  the ER), Vps10p  (a
protein marker of the Golgi), Pma1p (a protein marker of the PM) and Pho8p (a protein marker of the vacuole). 
  



















































We then quantitatively assessed the relative abundance 
of LCA in the membrane (i.e., the OMM and IMM) and 
soluble (i.e., the IMS and matrix) mitochondrial sub-
compartments by subjecting purified mitochondria to 



















































centrifugation. This fractionation approach results in a 
reconstruction of so-called submitochondrial particles 
(SMP). These vesicular particles (i) are depleted of 
protein and other components of the mitochondrial 





and  B)  or  to  fractionation  using  sonication  and  subsequent  differential  centrifugation  (C  and D).  (A  and  B)  The  percent
recoveries of  loaded protein and LCA  in sucrose gradient fractions are presented. Equal volumes of gradient fractions were
subjected to  lipid extraction followed by mass spectrometric  identification and quantitation of LCA  in the extracts of  lipids.
Equal volumes of gradient fractions were also analyzed by immunoblotting with antibodies to Por1p (a protein marker of the
OMM), Ccp1p  (a protein marker of  the  IMS), Cox2p  (a protein marker of  the  IMM)  and Mge1p  (a protein marker of  the
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and OMM resealed in the inside-out orientation [71]. 
High-speed centrifugation of sonicated mitochondria 
yields the pellet of SMP, whereas protein and other 
components of the mitochondrial matrix and IMS 
remain in the supernatant. We found that, in yeast 
cultured with LCA in the presence of DMSO or in its 
absence, this bile acid was confined mostly (from 
92.8% to 98.5% of the total pool of mitochondrial LCA) 
to the pellet of SMP (Figures 3C and 3D). Minor 
quantities of LCA (from 1.5% to 7.2% of the total pool 
of mitochondria-associated LCA) were recovered in the 
supernatant consisting of mitochondrial matrix and the 
IMS (Figures 3C and 3D). 
 
Altogether, our quantitative analysis of LCA recovered 
in various mitochondrial sub-compartments implies 
that, regardless of the presence of DMSO in yeast 
cultures containing exogenously added LCA, the 
mitochondria-associated pool of LCA resides mainly in 
the IMM. A smaller portion of this bile acid (from 
20.7% to 26.6% of the total pool of mitochondrial LCA) 
associates with the OMM. 
 
Mitochondrial membranes of yeast cultured in the 
presence of LCA exhibit altered concentrations of 
various glycerophospholipid species 
 
Glycerophospholipid compositions of both mito-
chondrial membranes depend on several processes that 

























dynamics within mitochondria and the ER. These 
processes include (i) the synthesis of the 
glycerophospholipids phosphatidic acid (PA), cytidine 
diphosphate-diacylglycerol (CDP-DAG), phosphatidyl-
serine (PS), phosphatidylcholine (PC) and phosphatidyl-
inositol (PI) by enzymes residing in the ER; (ii) the 
synthesis of the glycerophospholipids CDP-DAG, 
phosphatidylglycerol (PG), cardiolipin (CL) and 
monolysocardiolipin (MLCL) by enzymes confined to 
the IMM; (iii) a bidirectional movement of 
glycerophospholipids via mitochondria-ER junctions 
(also called mitochondria-ER contact sites), which 
represent zones of close apposition between the OMM 
and the mitochondria-associated membrane (MAM) 
domain of the ER; and (iv) a CL-dependent inhibition of 
PA transport from the OMM to the IMM by Ups1p, a 
protein that shuttles PA between the two mitochondrial 
membranes (Figure S1) [18, 20-22]. Based on our 
observation that in yeast cells cultured in the presence of 
exogenous LCA this most hydrophobic molecular form 
of bile acids accumulates in the IMM and is also present 
in the OMM (Figure 3), we hypothesized that LCA may 
alter the relative concentrations of various glycerophos-
pholipid species in mitochondrial membranes – perhaps 
by modulating activities of enzymes involved in 
glycerophospholipid synthesis within the IMM, affecting 
glycerophospholipid exchange between the mitochon-
drial and ER membranes via mitochondria-ER junctions, 
and/or impinging on the Ups1p-driven shuttling of PA 






























measurement  in  samples  of  purified  mitochondria,  extraction  of  mitochondrial  membrane  lipids,  and  mass
spectrometric  identification  and  quantitation  of  the  extracted  glycerophospholipid  species  were  carried  out  as
described in Methods. Based on these data, the “total membrane glycerophospholipids/total membrane protein” ratios
were  calculated  as  nmoles  of  glycerophospholipid/mg  of  protein  for  mitochondria  that  were  purified  from  cells
recovered on day 2, 4 or 7 of cell culturing. Data are presented as means ± SEM (n = 3; *p < 0.01; ns, not significant). 
  
















































To assess the validity of our hypothesis that 
mitochondria-confined LCA alters glycerophospholipid 
composition of mitochondrial membranes, we used 
mass spectrometry to compare the membrane lipidomes 
of mitochondria purified from yeast cultured under CR 
conditions with or without LCA, either in the presence 
of DMSO or in its absence. We found that, regardless of 
















































exogenously added LCA, this bile acid causes an 
increase in the glycerophospholipid/protein ratio 
(calculated as nmoles of glycerophospholipid/mg of 
protein) of mitochondrial membranes. It should be 
emphasized that LCA affects this ratio is in an age-
dependent manner. Indeed, LCA (i) had no effect on the 
glycerophospholipid/protein ratio of mitochondrial 
membranes in cells recovered at diauxic (D) growth 
Figure 5. LCA exhibits age‐dependent differential effects on the concentrations (calculated as nmoles of
glycerophospholipid/mg  of  protein)  of  different  species  of  mitochondrial  membrane  glycerophospho‐
lipids. Cells were cultured in the nutrient‐rich YP medium initially containing 0.2% glucose with 50 µM LCA or without
it,  in  the presence of  1% DMSO  (A, C  and  E)  or  in  its  absence  (B, D  and  F). Mitochondria were purified  from  cells
recovered on day 2, 4 or 7 of cell culturing. Protein concentration measurement  in samples of purified mitochondria,
extraction of mitochondrial membrane  lipids, and mass spectrometric  identification and quantitation of the extracted
glycerophospholipid  species were  carried out  as described  in Methods. Based on  these data,  the  concentrations of
different  molecular  forms  of  mitochondrial  membrane  glycerophospholipids  were  calculated  as  nmoles  of
glycerophospholipid/mg of protein  for mitochondria  that were purified  from cells  recovered on day 2, 4 or 7 of cell
culturing. Data are presented as means ± SEM (n = 3; *p < 0.01; ns, not significant). 
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phase on day 2 of cell culturing; (ii) caused a moderate 
(but significant) increase in this ratio in cells recovered 
at post-diauxic (PD) growth phase on day 4 of cell 
culturing; and (iii) significantly elevated the 
glycerophospholipid/protein ratio of mitochondrial 
membranes in cells recovered at stationary (ST) growth 
phase on day 7 of cell culturing, upon entry into a 
quiescent state (Figure 4). 
 
It needs to be emphasized that, regardless of the presence 
of DMSO in yeast cultures containing exogenously added 
LCA, this bile acid exhibited differential effects on the 
concentrations of different molecular forms of 
mitochondrial membrane glycerophospholipids; 
moreover, these effects of LCA were age-dependent. 
Indeed, we found that (i) LCA causes a rise in the levels 
of mitochondrial PA, PG, PS, PC and PI calculated as 
nmoles of glycerophospholipid/mg of protein; (ii)  the 
extent of such effect of LCA on PA, PG, PS, PC and PI 
levels (calculated as nmoles of glycerophospholipid/mg 
of protein) increases with the chronological age of yeast 
cells; and (iii) for the PG and PI species of mitochondrial 
membrane glycerophospho-lipids, this effect of LCA can 
be seen only in cells recovered at PD or ST growth phase 
on day 4 or 7 (respectively) of cell culturing (Figure 5).  
 
In contrast, our mass spectrometric identification and 
quantitation of mitochondrial membrane 
glycerophospholipids revealed that (i) LCA elicits a 
decline in the levels of mitochondrial CL, MLCL and PE 
calculated as nmoles of glycerophospholipid/mg of 
protein; (ii) the extent of such effect of LCA on CL, 
MLCL and PE levels (calculated as nmoles of 
glycerophospholipid/mg of protein) decreases with the 
chronological age of yeast cells; and (iii) for the MLCL 
species of mitochondrial membrane glycerophospho-
lipids, this effect of LCA can be seen only in cells 
recovered at PD or ST growth phase on day 4 or 7 
(respectively) of cell culturing (Figure 5). 
 
It should be stressed that, although a similar (but not 
identical) trend of the differential effect of LCA on the 
concentrations of different molecular forms of mito-
chondrial membrane glycerophospholipids was observed 
if their relative levels were calculated as mol% of all 
glycerophospholipids, the extent to which LCA increased 
the relative levels of mitochondrial PA, PG, PS and PC or 
decreased the relative levels of mitochondrial CL, MLCL 
and PE gradually progressed with the chronological age 
of yeast cells (Figure 6). Moreover, LCA did not alter the 
relative level of PI if it was calculated as mol% of all 
glycerophospholipids (Figure 6). 
 
Importantly, while LCA elicited substantial differential 
effects on the relative levels of different molecular 
forms of mitochondrial membrane glycerophospholipids 
(calculated as mol% of all glycerophospholipids), it did 
not cause a significant change in the “unsaturation 
index” for any of the glycerophospholipid species 
(Figure S2). This index  is calculated as the “glycero-
phospholipids with one, two, three or four unsaturated 
acyl chains (i.e., Cn:1, Cn:2, Cn:3 and Cn:4 
species)/glycerophospholipids without unsaturated acyl 
chains (i.e., Cn:0 species)” ratio [72]. We found that the 
unsaturation index was high for each molecular form of 
mitochondrial membrane glycerophospholipids, ranging 
from 4.2 to 63.3 (Figure S2). For PG, PS, PC, PI and 
PE, the unsaturation index is known to play a pivotal 
role in defining whether each of these 
glycerophospholipid species acquires the bilayer 
forming shape of a cylinder or it attains the non-bilayer 
forming shape, either that of a cone or an inverted cone 
(Figures 7A-7D) [18, 73, 74]. On note, PA, CL and 
MLCL are known to be always present in the non-
bilayer forming shape of a cone, regardless of their 
unsaturation indexes (Figures 7A-7D) [18, 73]. Thus, 
the observed differential effects of LCA on the relative 
levels of different molecular forms of mitochondrial 
membrane glycerophospholipids (Figure 6; calculated 
as mol% of all glycerophospholipids) and the 
demonstrated lack of its effect on the unsaturation index 
for each of these molecular forms (Figure S2) imply 
that this bile acid alters only the relative levels of 
bilayer forming and non-bilayer forming 
glycerophospholipid species, but does not affect the 
molecular shape of any of them. 
 
Mitochondrial membranes of yeast cultured in the 
presence of LCA display reduced concentrations of 
non-bilayer forming glycerophospholipids and elevat-
ed concentrations of their bilayer forming species 
 
The shape of a glycerophospholipid molecule is defined 
by the relative sizes of the cross-sectional areas of its 
hydrophilic head group and hydrophobic acyl chains 
(Figures 7A-7C) [18, 73, 74]. If the cross-sectional 
areas of the hydrophilic head group and hydrophobic 
acyl chains of a glycerophospholipid are equally sized, 
it has a cylindrical shape (Figure 7C) [18, 73, 74]. A 
glycerophospholipid whose hydrophilic head group is 
smaller than the cross-sectional area of the hydrophobic 
acyl chains has a cone shape, whereas a 
glycerophospholipid that exhibits the opposite trend is 
shaped as an inverted cone (Figure 7C) [18, 73, 74]. 
 
The relative levels of cylinder-, cone- and inverted 
cone-shaped glycerophospholipids in a membrane are 
known to define membrane curvature; thus, changes in 
the relative levels of the differently shaped lipids within 
a membrane can alter its curvature [18, 73, 74]. For the 
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IMM, a rise in the relative levels of glycero-
phospholipids having the bilayer forming shape of a 
cylinder reduces the extent of membrane curving [18, 
73, 74]. This, in turn, causes the following three kinds 
of simultaneous changes in mitochondrial 
morphology: (i) an increase in the abundance of the 
IMM domains exhibiting so-called “flat” bilayer 
conformation; (ii) a reduction in the abundance of the 
IMM domains displaying negative curvature (i.e., 
membrane curving away from the mitochondrial 












































between the IMM and OMM; and (iii) a decline in the 
abundance of the IMM domains having positive 
curvature (i.e., membrane curving towards the 
mitochondrial matrix) characteristic of mitochondrial 
cristae formed by the IMM (Figure 7D) [18, 73, 74]. 
Furthermore, the concurrent rise in the relative levels 
of cone- and inverted cone-shaped glycerophospho-
lipids, both being non-bilayer forming species, 
elevates the extent of membrane curving to increase 
the abundance of mitochondrial contact sites and 













































Figure  6.  LCA  exhibits  age‐dependent  differential  effects  on  the  relative  levels  (calculated  as  mol%  of  all
glycerophospholipids)  of  different molecular  forms  of mitochondrial membrane  glycerophospholipids.  Cells were
cultured in the nutrient‐rich YP medium initially containing 0.2% glucose with 50 µM LCA or without it, in the presence of 1% DMSO
(A, C and E) or  in  its absence  (B, D and  F). Mitochondria were purified  from  cells  recovered on day 2, 4 or 7 of  cell  culturing.
Extraction of mitochondrial membrane  lipids, and mass spectrometric  identification and quantitation of  the glycerophospholipid
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Based on our data on mass spectrometric identification 
and quantitation of mitochondrial membrane 
glycerophospholipids, we calculated the relative levels of 
their species having the non-bilayer forming shape of a 
cone or an inverted cone as well as the relative levels of 
glycerophospholipid species exhibiting the bilayer 
forming shape of a cylinder. The relative levels of non-
bilayer forming and bilayer forming glycerophospho-
lipids were calculated as mol% of all membrane 
glycerophospholipids. We found that, regardless of the 
presence of DMSO in yeast cultures containing 
exogenously added LCA, this bile acid reduces the 
relative levels of non-bilayer forming glycerophospho-
lipids (Figures 7E and 7F) and elevates the relative levels 
of their bilayer forming species (Figures 7G and 7H). We 
therefore hypothesized that LCA may (i) reduce the 
abundance of the IMM domains displaying negative 
curvature characteristic of mitochondrial contact sites 
between the IMM and OMM; (ii) decrease the abundance 
of the IMM domains exhibiting positive curvature typical 
of mitochondrial cristae formed by the IMM; and (iii) 
increase the abundance of the IMM domains having flat 
bilayer conformation. 
 
Mitochondria of yeast cultured in the presence of 
LCA are enlarged, their number is reduced and 
their morphology is altered 
 
Membrane lipids are known to influence the physical 
properties of biological membranes, thereby having a 
significant impact on their structure and function [18, 
72, 75, 76]. As for mitochondrial membranes, their 
glycerophospholipid compositions and the relative 
abundance of several glycerophospholipid species 
within the IMM and OMM have been shown to define 
the morphology of mitochondria [18, 77-79]. Because 
LCA causes an age-related increase in the 
glycerophospholipid/protein ratio of mitochondrial 
membranes and differentially affects (in an age-
dependent manner) the relative levels of different 
molecular forms of glycerophospholipids within these 
membranes, we sought to investigate how LCA 
influences mitochondrial morphology and abundance in 
chronologically aging yeast. Our electron microscopical 
analysis revealed that in yeast cells grown under CR on 
0.2% glucose and recovered upon entry into a quiescent 
state on day 7 of cell culturing, LCA (i) causes a 
substantial enlargement of mitochondria (Figures 8C 
and 8I); and (ii) significantly reduces the number of 
these organelles (Figures 8D and 8J). Noteworthy, LCA 
elicited these characteristic changes in mitochondrial 
size and number regardless of the presence of DMSO in 
yeast cultures containing exogenously added LCA 
(compare Figures 8A-8D to Figures 8G-8J). It is likely 
that the substantial enlargement of mitochondria and the 
resulting expansion of both mitochondrial membranes 
observed in yeast cultured with exogenously added 
LCA (Figures 8A-8C and Figures 8G-8I) were due to 
the age-related increase in the glycerophospho-
lipid/protein ratio (and, thus, in glycerophospholipid 
abundance) of mitochondrial membranes seen in these 
cells (Figure 4). Moreover, it is conceivable that the 
significant decrease in mitochondrial number in yeast 
grown in the presence of exogenous LCA (Figures 8A, 
8B, 8D, 8G, 8H and 8J) was caused by the differential 
effects of this bile acid on the relative levels of different 
glycerophospholipid species (calculated as mol% of all 
glycerophospholipids) within mitochondrial membranes 
(Figure 6). Indeed, LCA increased the relative level of 
mitochondrial PA (Figure 6), a glycerophospholipid 
known to elicit a reduction in mitochondrial number by 
stimulating fusion of small mitochondria [18, 80, 81]. 
 
In yeast cells grown under CR on 0.2% glucose and 
recovered upon entry into a quiescent state on day 7 of 
cell culturing, LCA also alters the morphological 
appearance of the IMM and mitochondrial cristae. 
Indeed, our electron microscopical analysis revealed 
that this bile acid (i) substantially lowers the proportion 
of mitochondria with cristae extending from the IMM 
by reducing the extent of connectivity between cristae 
and the inner boundary membrane (Figures 8A, 8B, 8E, 
8G, 8H and 8K); and (ii) significantly increases the total 
length of mitochondrial cristae (including both cristae 
extending from the IMM and cristae disconnected from 
the inner boundary membrane) relative to the total 
length of the OMM (Figures 8A, 8B, 8F, 8G, 8H and 
8L). The formation of mitochondrial cristae by the IMM 
domains having positive curvature (i.e., membrane 
curving towards the mitochondrial matrix) is known to 
require both glycerophospholipids having the non-
bilayer forming shape of a cone and 
glycerophospholipids exhibiting the non-bilayer 
forming shape of an inverted cone (Figure 7D) [18, 73, 
74]. Therefore, it is conceivable that the substantial 
changes in morphology of the IMM and mitochondrial 
cristae observed in yeast cultured with exogenously 
added LCA (Figures 8A, 8B, 8E-8H, 8K and 8L) were 
due to the significant reduction in the relative levels of 
non-bilayer forming (i.e.,  cone- and inverted cone-
shaped) mitochondrial glycerophospholipids seen in 
these cells (Figures 7E and 7F). Moreover, it is 
plausible that the observed in yeast grown in the 
presence of exogenous LCA build-up within the 
mitochondrial matrix of cristae disconnected from the 
IMM and thus exhibiting flat bilayer conformation 
(Figures 8A, 8B, 8E-8H, 8K and 8L) was caused by the 
substantial rise in the relative levels of bilayer forming 
(i.e., cylinder-shaped) mitochondrial glycerophospho-
lipids seen in these cells (Figures 7G and 7H). 
  





















































































































inverted  cone‐shaped glycerophospholipids  in a membrane define membrane curvature,  including  that of  the  IMM. See
text for details. (E ‐ H) Cells were cultured in the nutrient‐rich YP medium initially containing 0.2% glucose with 50 µM LCA
or without  it,  in  the presence of 1% DMSO  (E and G) or  in  its absence  (F and H). Mitochondria were purified  from cells
recovered  on  day  2,  4  or  7  of  cell  culturing.  Extraction  of  mitochondrial  membrane  lipids,  and  mass  spectrometric




















































































































Figure 8.  LCA enlarges mitochondria,  reduces  their number and alters  their morphology. Cells were  cultured  in  the
nutrient‐rich YP medium initially containing 0.2% glucose with 50 µM LCA or without it, in the presence of 1% DMSO (A ‐ F) or in its
absence  (G  ‐  L).  (A,  B,  G  and  H)  Transmission  electron  micrographs  of  yeast  cells  recovered  on  day  7  of  cell  culturing.  M,
mitochondrion. Bar, 1 µm. (C and  I) Percentage of mitochondria having the  indicated relative area of mitochondrion section. The






cells  were  subjected  to  morphometric  analysis  for  each  kind  of  culturing  conditions;  *p  <  0.01).  (F  and  L)  Percentage  of
mitochondria  having  the  indicated  relative  length  of mitochondrion  cristae.  The  relative  length  of mitochondrion  cristae was
calculated as  [the  total  length of mitochondrial cristae  (including both cristae extending  from  the  IMM and cristae disconnected
from  the  inner boundary membrane)/the  total  length of  the OMM] ¯ 100%. Data are presented as means ± SEM  (transmission
electron micrographs of at least 100 cells were subjected to morphometric analysis for each kind of culturing conditions; *p < 0.01).
  

















































Mitochondria of yeast cultured in the presence of 
LCA exhibit altered functionality 
 
Because LCA causes major changes in mitochondrial 
morphology and abundance in chronologically aging 
yeast, we sought to examine its effect on the age-related 

















































are confined to and regulated by mitochondria. We 
found that in yeast cells grown under CR on 0.2% 
glucose and recovered at different periods of 
chronological lifespan, LCA alters the age-related 
chronology of changes in vital mitochondrial processes, 
including (i) mitochondrial respiration; (ii) the 
maintenance of electrochemical potential across the 
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IMM; and (iii) the establishment of a steady-state level 
of intracellular reactive oxygen species (ROS) known to 
be generated mainly as by-products of mitochondrial 
respiration [82]. In yeast cultured in the absence of 
exogenous LCA, with or without DMSO, the efficacies 
of these three processes were (i) greatly amplified when 
yeast entered D growth phase on day 2 of cell culturing; 
and (ii) sharply declined through the subsequent PD and 
ST growth phases (Figures 9A-9C and 9E-9G). In yeast 
cultured in the presence of exogenous LCA, with or 
without DMSO, the efficacies of all these processes 
were (i) increased to a much lesser extent during D 
phase than they were increased in yeast cultured in the 
absence of LCA; and (ii) reached a plateau in PD phase 
and remained mainly unchanged during the subsequent 
ST phase (Figures 9A-9C and 9E-9G). It needs to be 
emphasized that, following entry of yeast cells into a 
quiescent state (i.e., during ST phase), the efficacies of 
all three monitored mitochondrial processes in yeast 
cultured in the presence of exogenous LCA (with or 
without DMSO) significantly exceeded those in yeast 
cultured in its absence (Figures 9A-9C and 9E-9G). 
 
Furthermore, in yeast grown under CR on 0.2% glucose 
and recovered at different periods of chronological 
lifespan, LCA altered the age-related dynamics of 
changes in the cellular level of ATP, which in yeast 
limited in calorie supply is known to be produced 
mainly in mitochondria [83]. Indeed, we found that 
during PD and ST phases the level of ATP in yeast cells 
cultured under CR conditions in the presence of 
exogenous LCA (with or without DMSO) considerably 
exceeds that detected in yeast cultured in its absence 
(Figures 9D and 9H). 
 
 Altogether, these findings imply that in chronologically 
aging yeast LCA alters the age-related chronology of 
four longevity-defining cellular processes confined to 
and regulated by mitochondria. It is conceivable that 
mitochondria in chronologically “old” cells cultured 
with exogenous LCA respire more efficiently, maintain 
higher electrochemical potential across the IMM, 
sustain greater steady-state concentration of 
intracellular ROS and preserve elevated cellular level of 
ATP (as compared to mitochondria in age-matched cells 
cultured without LCA; Figure 9) because of the 
substantial changes in morphology of the IMM and 
mitochondrial cristae (Figure 8), which in cells exposed 
to LCA are likely to be caused by the significant 
reduction in the relative levels of non-bilayer forming 
mitochondrial glycerophospholipids (Figure 7). Indeed, 
the non-bilayer forming glycerophospholipids PE and 
CL have been implicated in regulating mitochondrial 
respiration, membrane potential, ROS homeostasis and 
ATP synthesis, the vital processes driven by protein 
complexes that reside in the IMM and mitochondrial 
cristae [18, 77, 84]. 
 
Noteworthy, the observed ability of mitochondria in 
chronologically “old” cells cultured with exogenous 
LCA to sustain intracellular ROS at the steady-state 
level exceeding that in age-matched cells cultured 
without LCA (Figures 9C and 9G) is likely to play an 
important role in longevity extension by this bile acid. 
Indeed, recent findings imply that mitochondria-derived 
ROS can delay chronological aging in yeast if their 
steady-state cellular concentrations are maintained at a 
certain “optimal”, non-toxic level [9, 13, 41]. This 
“optimal”, sub-lethal level of mitochondria-derived 
ROS is insufficient to cause a substantial oxidative 
damage to cellular constituents but can stimulate 
“stress-response hormesis” by activating an intricate 
signaling network that in response specifically alters 
epigenetic and gene expression patterns to cause 




In this study, we provide the first evidence that 
mitochondrial membrane lipidome plays an essential 
role in defining yeast longevity. This conclusion is 
based on our findings that LCA, a longevity-extending 
hydrophobic bile acid [44], delays chronological aging 
in yeast by accumulating in both mitochondrial 
membranes and altering their glycerophospholipid 
compositions. The elicited by LCA differential effects 
on the relative levels of different molecular forms of 
mitochondrial membrane glycerophospholipids cause 
major changes in mitochondrial size, number and 
morphology. This, in turn, alters the age-related 
dynamics of vital longevity-defining cellular processes 
confined to and regulated by mitochondria, thereby 
greatly extending the lifespan of chronologically aging 
yeast. It needs to be emphasized that LCA exhibits all 
these effects in yeast cells cultured under longevity-
extending CR conditions and, thus, acts in synergy with 
CR to enable a significant further increase in 
chronological lifespan by accumulating in both 
mitochondrial membranes and altering their lipidomes. 
 
Based on our findings, we propose the following model 
for a mechanism underlying the ability of LCA to 
extend yeast longevity by accumulating in mito-
chondria, altering mitochondrial membrane lipidome, 
and affecting mitochondrial morphology and function 
(Figure 10). Exogenously added LCA enters yeast cells 
and is sorted to mitochondria. Although in the presence 
of DMSO used as a vehicle for delivering exogenous 
LCA into a cell it also resides in the cytosol, the almost 
exclusive confinement of the intracellular pool of this 
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bile acid to mitochondria if added without DMSO 
implies that, regardless of the presence of DMSO in 
yeast cultures, the potent anti-aging effect of LCA is 
due to its accumulation in mitochondria. Almost 75% of 
the total pool of mitochondrial LCA resides in the IMM, 
and approximately 25% of this pool is also confined to 
the OMM (Figure 10). 
 
In our model, the accumulated in the IMM pool of LCA 
elicits differential effects on activities of different 
enzymes involved in glycerophospholipid synthesis 
within the inner boundary membrane. The most likely 
explanation for the observed in LCA-treated cells 
changes in the relative levels of various molecular 
forms of mitochondrial membrane glycerophospholipids 
is that this bile acid specifically alters the hydrophobic 
environment within the IMM to slow down the Psd1p- 
and Crd1p-dependent reactions (Figure 10); the Psd1p 
reaction is known to lead to the conversion of PS to PE, 
whereas the Crd1p reaction produces CL from PG [18, 
20]. The resulting decline in the concentration of newly 
synthesized CL limits its availability for the later acyl 
chain remodeling steps (Figure 10), which involve the 
sequential action of the phospholipase Cld1p and the 
transacylase Taz1p [18, 20]. This, in turn, lowers the 
level of MLCL as well as reduces the flow and elevates 
the level of PC (Figure 10), the only known donor of 
acyl chains for the remodeling of newly synthesized CL 
[18, 20]. Our model also posits that the elicited by LCA 
decline in the level of CL within the IMM attenuates a 
negative feedback loop that involves a CL-dependent 
inhibition of PA transport from the OMM to the IMM 
by Ups1p, a protein that shuttles PA between the two 
mitochondrial membranes (Figure 10) [20]. The 
acceleration of the Ups1p-driven transport of PA from 
the OMM to the IMM may in turn accelerate the 
movement of PA from the MAM domain of the ER to 
the OMM; such movement is known to occur via 
mitochondria-ER junctions [18, 20, 21] and could be 
stimulated by the accumulated in the OMM pool of 
LCA (Figure 10). The facilitated by LCA transport of 
PA from the MAM domain of the ER to the OMM and 
then to the IMM acts synergistically with the 
aforementioned LCA-dependent deceleration of the 
Crd1p reaction to increase the levels of PA and PG 
within the IMM (Figure 10). Altogether, such 
remodeling of glycerophospholipid synthesis within the 
IMM, attenuation of the CL-dependent inhibition of PA 
transport from the OMM to the IMM and acceleration 
of PA movement from the MAM domain of the ER to 
the OMM in cells cultured with LA cause: (i) a decline 
in the relative levels of PE, CL and MLCL within 
mitochondrial membranes; and (ii) a rise in the relative 
levels of PA, PS, PC and PG within mitochondrial 
membranes (Figure 10). In our model, none of these 
LCA-driven processes in the IMM and OMM alters the 
relative level of PI within mitochondrial membranes 
(Figure 10), just as it was demonstrated by our mass 
spectrometric quantitation of various molecular forms 
of mitochondrial membrane glycerophospholipids 
(Figure 6). 
 
Our model envisions that the LCA-driven progressive 
remodeling of mitochondrial glycerophospholipid 
synthesis and transport with the chronological age of a 
yeast cell causes significant changes in mitochondrial 
membrane lipidome, thereby eliciting major changes in 
mitochondrial abundance and morphology. These age-
related changes include: (i) an increase in the abundance 
of mitochondrial glycerophospholipids (Figure 4), 
thereby leading to an expansion of both mitochondrial 
membranes and the resulting enlargement of 
mitochondria (Figure 8); (ii) a rise in the level of 
mitochondrial PA (Figure 6), thereby eliciting a 
reduction in mitochondrial number (Figure 8) - perhaps 
by stimulating mitochondrial fusion known to be 
activated by PA [18, 80, 81]; (iii) a decline in the 
relative levels of non-bilayer forming (i.e.,  cone- and 
inverted cone-shaped) mitochondrial glycerophospho-
lipids (Figure 7), thereby causing a decrease in the 
proportion of mitochondria with cristae extending from 
the IMM (Figure 8) - possibly because mitochondrial 
cristae formation by the IMM domains having positive 
curvature is known to require both these differently 
shaped non-bilayer forming glycerophospholipids [18, 
73, 74]; and (iv) a rise in the relative levels of bilayer 
forming (i.e., cylinder-shaped) mitochondrial 
glycerophospholipids (Figure 7), thereby leading to an 
accumulation within the mitochondrial matrix of cristae 
disconnected from the IMM and thus exhibiting flat 
bilayer conformation (Figure 8) - perhaps due to the 
known ability of bilayer forming glycerophospholipids 
to reduce the extent of membrane curving [18, 73, 74]. 
 
Our model also posits that the elicited by LCA 
substantial changes in mitochondrial membrane 
lipidome and the resulting major changes in 
mitochondrial morphology act in synergy to alter the 
age-related chronology of mitochondrial respiration, 
electrochemical membrane potential, ATP synthesis and 
ROS homeostasis (Figure 10). All these longevity-
defining processes are driven by protein complexes and 
supercomplexes that are known (i) to reside in the IMM 
and mitochondrial cristae [86-88]; and (ii) to be 
regulated by PE and CL [18, 77, 84], the two non-
bilayer forming membrane glycerophospholipids whose 
levels are significantly reduced by LCA (Figure 6). 
Because of these LCA-dependent changes in the age-
related dynamics of the four longevity-defining 
processes confined to mitochondria, chronologically 
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“old” cells cultured with exogenous LCA exhibit higher 
(as compared to age-matched cells cultured without 
LCA) mitochondrial respiration, electrochemical 
membrane potential, ATP level and ROS concentration 
(Figures 9 and 10). The elevated efficacies of mito-
chondrial respiration, electrochemical membrane 
potential maintenance and ATP synthesis in 
chronologically “old”, quiescent yeast cells are known 














































their longevity (Figure 10) [9, 11, 39, 41, 42, 47]. 
Moreover, the elevated to a sub-lethal level intracellular 
concentrations of mitochondrially generated ROS in 
chronologically “old”, quiescent yeast cells have been 
shown to increase their long-term stress resistance and, 
thus, to extend their longevity by activating an elaborate 
signaling network that establishes specific anti-aging 
epigenetic and gene expression patterns (Figure 10) [9, 
11, 13, 39, 41, 89]. 
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Figure 10. A model for a mechanism underlying the ability of LCA to extend yeast longevity by accumulating in








and  the  resulting  major  changes  in  mitochondrial  morphology  act  in  synergy  to  alter  the  age‐related  chronology  of
mitochondrial  respiration, electrochemical membrane potential, ATP  synthesis and ROS homeostasis. Because of  these  LCA‐
dependent  changes  in  the  age‐related  dynamics  of  the  four  longevity‐defining  processes  confined  to  mitochondria,
chronologically “old” cells cultured with exogenous LCA exhibit higher (as compared to age‐matched cells cultured without LCA)
mitochondrial  respiration, electrochemical membrane potential, ATP  level and ROS  concentration. This  increases  their  long‐
term viability and stress resistance and, thus, extends their longevity. Arrows next to the names of lipid species denote those of
them whose  concentrations  are  elevated  (red  arrows)  or  reduced  (blue  arrows)  in  cells  cultured with  exogenous  LCA  and
therefore accumulating this bile acid in the IMM and OMM. Activation arrows and inhibition bars displayed in red color denote
anti‐aging  processes.  See  text  for  details.  Abbreviations:  CDP‐DAG,  cytidine  diphosphate‐diacylglycerol;  MLCL,
monolysocardiolipin; PC, phosphatidylcholine; PG, phosphatidylglycerol; PI, phosphatidylinositol; PS, phosphatidylserine. 
The elevated mitochondrial respiration, electrochemical 
membrane potential, ATP level and ROS concentration 
observed during ST phase in chronologically “old” cells 
cultured with exogenous LCA (as compared to those in 
age-matched cells cultured without LCA) (Figures 9 
and 10) could be due to the ability of this bile acid to 
lower the concentration of mitochondrially generated 
ROS below a toxic threshold during D phase in 
chronologically “young” cells (Figure 9). It is 
conceivable that the lowered, non-toxic intracellular 
concentration of ROS observed in chronologically 
“young” cells cultured with LCA reduces the extent of 
oxidative damage to mitochondrial macromolecules 
early in life, thereby supporting long-term cell viability 
by allowing mitochondria-confined proteins, lipids and 
DNA involved in mitochondrial respiration, membrane 
potential maintenance and ATP synthesis to maintain 
their functionality late in life. 
           
The major challenge now is to get a greater insight into 
mechanisms that in chronologically aging yeast cultured 
with exogenous LCA underly (i) the entry of LCA into 
a yeast cell and its accumulation in the IMM and OMM; 
(ii) the LCA-driven remodeling of mitochondrial 
membrane lipidome in an age-dependent fashion; (iii) 
the major changes in mitochondrial size, number and 
morphology, all of which according to our model (see 
Figure 10) are due to the observed differential effects of 
mitochondria-confined LCA on the relative levels of 
different molecular forms of mitochondrial membrane 
glycerophospholipids; and (iv) the LCA-dependent 
alterations in the age-related chronology of 
mitochondrial respiration, electrochemical membrane 
potential, ATP synthesis and ROS homeostasis, each of 
which according to our model (see Figure 10) is a 
conceivable outcome of a synergy between substantial 
changes in mitochondrial membrane lipidome and the 
resulting major changes in mitochondrial morphology. 
To address this challenge, several important questions 
need to be answered. What are the identities of cellular 
proteins involved in the translocation of exogenously 
added LCA across the plasma membrane, its delivery to 
mitochondria, and its incorporation into the IMM and 
OMM? Are any of these proteins known for their 
essential role in defining yeast longevity? Will genetic 
manipulations eliminating any of these proteins or 
altering their levels affect the extent of LCA 
accumulation in a yeast cell, the efficacy of LCA 
sorting to any of the two mitochondrial membranes 
and/or the magnitude of longevity extension by 
exogenous LCA? How does the accumulation of LCA 
in the IMM influence (i) the activities of Psd1p, Crd1p 
and other enzymes involved in the outlined in Figure 10 
pathways for glycerophospholipid synthesis within the 
inner boundary membrane; and (ii) the stabilities of 
newly synthesized PE, CL, MLCL and other species of 
glycerophospholipids formed within the IMM? What 
are the effects of LCA accumulation in the IMM and 
OMM on (i) the Ups1p-driven transport of PA from the 
OMM to the IMM; and (ii) the movement of PA from 
the MAM domain of the ER to the OMM via 
mitochondria-ER junctions? How will genetic 
manipulations eliminating (or altering levels of) any of 
the proteins involved in glycerophospholipid synthesis 
within the IMM, PA transport from the OMM to the 
IMM or PA movement via mitochondria-ER junctions 
(as outlined in Figure 10) influence: (i) the LCA-
dependent changes in mitochondrial size, number and/or 
morphology; (ii) the LCA-dependent alterations in the 
age-related chronology of mitochondrial respiration, 
electrochemical membrane potential, ATP synthesis and 
ROS homeostasis; and/or (iii) the magnitude of longevity 
extension by exogenous LCA? We shall have to answer 
these important questions if we want to understand the 
inherent complexity of the mechanisms and biological 
principles underlying the demonstrated in this study 
essential role of mitochondrial membrane lipidome in 




Yeast strains, media and growth conditions. The wild-
type strain Saccharomyces cerevisiae BY4742 (MATα 
his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0) [Thermo 
Scientific/Open Biosystems; #YSC1054] was grown in 
YP medium (1% yeast extract, 2% peptone) [both from 
Fisher Scientific; #BP1422-2 and #BP1420-2, 
respectively] containing 0.2% glucose [#D16-10; Fisher 
Scientific] as carbon source. Cells were cultured at 30oC 
with rotational shaking at 200 rpm in Erlenmeyer flasks 
at a “flask volume/medium volume” ratio of 5:1. 
 
Pharmacological manipulation of chronological 
lifespan. Chronological lifespan assay and pharma-
cological manipulation of chronological lifespan by 
addition of lithocholic acid (LCA) [Sigma; #L6250] 
were performed as previously described [37, 44]. The 
stock solution of LCA in dimethyl sulfoxide (DMSO) 
was made on the day of adding this compound to cell 
cultures. LCA was added to growth medium in DMSO 
or water at the final concentration of 50 µM 
immediately following cell inoculation into the 
medium. The final concentration of DMSO in yeast 
cultures supplemented with LCA (and in the 
corresponding control cultures supplemented with 
compound vehicle) was 1% (v/v). 
 
Quantitative analysis of LCA associated with cells or 
remaining in the cultural medium. Yeast cells cultured 
in the presence of LCA were pelleted by centrifugation 
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for 5 min at 3,000 × g at room temperature. The 
recovered supernatant of the cultural medium was 
stored at room temperature. The recovered pellet of 
cells was washed twice with distilled water; the 
supernatant recovered after each centrifugation was 
combined with the cultural medium. An established 
procedure [90] was used for lipid extraction from the 
washed cells and from the cultural medium combined 
with the two washes. Mass spectrometric identification 
and quantitation of LCA in the extracts of lipids was 
performed as previously described [37]. 
 
Quantitative analysis of LCA recovered in subcellular 
fractions separated by differential centrifugation. 
Subcellular fractionation of yeast cell homogenates 
through sequential centrifugation steps of increasing 
force and duration [91], lipid extraction from the 
recovered subcellular fractions [90], and mass 
spectrometric identification and quantitation of LCA in 
the extracts of lipids [37] were performed according to 
established procedures. 
 
Quantitative analysis of LCA recovered in organelles 
pelleted by centrifugation at 12,000 × g and then 
separated by equilibrium density gradient 
centrifugation. A mix of mitochondria, endoplasmic 
reticulum, Golgi, vacuoles, plasma membrane and 
nuclei was recovered in a 12,000 × g pellet by 
sequential centrifugation of yeast cell homogenates at 
1,000 × g and 12,000 × g as previously described [91]. 
An established procedure [70] was used for separating 
the recovered mix of organelles by centrifugation to 
equilibrium in a sucrose density gradient. Lipid 
extraction from equal volumes of gradient fractions 
[90], and mass spectrometric identification and 
quantitation of LCA in the extracts of lipids [37] were 
performed according to established procedures. 
 
Subfractionation of purified mitochondria using a swell-
shrink procedure and equilibrium density gradient 
centrifugation. Mitochondria purified as previously 
described [70] were subjected to subfractionation using 
a modified swell-shrink procedure and subsequent 
equilibrium density gradient centrifugation [71]. 
Briefly, the purified mitochondria were resuspended in 
hypotonic buffer KH (10 mM KCl, 2 mM HEPES, pH 
7.2) at 2 mg/ml with gentle agitation for 20 min on ice. 
This caused the mitochondria to swell, ruptured the 
outer mitochondrial membrane (OMM) and resulted in 
the formation of mitoplasts consisting of mitochondrial 
matrix surrounded by the intact inner mitochondrial 
membrane (IMM). One-third volume of hypertonic 
buffer SAMH (1.8 M sucrose, 2 mM ATP, 2 mM 
MgSO4, 2 mM HEPES, pH 7.2) was then added and the 
mitoplasts attached to ruptured OMM vesicles were 
subjected to gentle homogenization for an additional 10 
min. This caused the mitoplasts to shrink, disrupted the 
OMM/IMM contact sites and resulted in the release of 
ruptured OMM vesicles. The swollen/shrunk 
mitochondrial suspension was then subjected to 
centrifugation on a discontinuous sucrose (26, 34.2, 
45.2 and 61.6%; wt/v in KH buffer) gradient at 75,000 
× g for 3 h at 4°C in a SW28 rotor (Beckman Coulter). 
19 fractions of 2 ml each were collected. Equal volumes 
of gradient fractions were subjected to SDS-PAGE and 
immunoblotting with antibodies to Por1p (a protein 
marker of the OMM fraction), Ccp1p (a protein marker 
of the intermembrane space [IMS] fraction), Cox2p (a 
protein marker of the IMM fraction) and Mge1p (a 
protein marker of the matrix fraction). Lipid extraction 
from equal volumes of gradient fractions [90], and mass 
spectrometric identification and quantitation of LCA in 
the extracts of lipids [37] were performed according to 
established procedures. 
 
Subfractionation of purified mitochondria using 
sonication and differential centrifugation. Mitochondria 
purified as previously described [70] were subjected to 
subfractionation using a modified procedure of 
sonication and subsequent differential centrifugation 
[71]. The procedure results in a reconstruction of so-
called submitochondrial particles (SMP) depleted of 
protein and other components of the mitochondrial 
matrix and IMS; these vesicular particles are 
surrounded by the IMM and OMM that are resealed in 
the inside-out orientation [71]. To reconstruct SMP, the 
purified mitochondria were gently resuspended in buffer 
SEH (250 mM sucrose, 2 mM EGTA, 5 mM HEPES, 
pH 7.2) at 2 mg/ml on ice. The suspension of 
mitochondria was sonicated 3 × 1 min on ice with 1 min 
intervals. The sonicated suspension was then subjected 
to centrifugation for 10 min at 12,000 × g at 4oC to 
remove unbroken mitochondria. The recovered 
supernatant was spun for 45 min at 120,000 × g at 4oC 
to yield the pellet of SMP and the supernatant 
containing protein and other components of the 
mitochondrial matrix and IMS. The pellet of SMP was 
gently resuspended in ice-cold SEH buffer and spun for 
45 min at 120,000 × g at 4oC to wash and re-pellet 
SMP. 
 
Miscellaneous procedures. Electron microscopy and the 
morphometric analysis of the resulting images were 
performed as previously described [92]. Protein 
concentration in samples of purified mitochondria was 
determined with an RC DC protein assay kit (#500-
0122; Bio-Rad) following the manufacturer's 
instructions. SDS-PAGE and immunoblotting using a 
Trans-Blot SD semi-dry electrophoretic transfer system 
(#170-3940; Bio-Rad) were performed according to 
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established procedures [93]. Blots were decorated with 
monoclonal antibodies raised against Por1p (#459500; 
Invitrogen), Nsp1p (#ab4641; Abcam), Dpm1p 
(ab113686; Abcam), Vps10p (#A21274; Invitrogen), 
Pma1p (ab4645; Abcam), Pho8p (ab113688; Abcam) or 
polyclonal antisera raised against Cox2p (a kind gift of 
Dr. Carla Koehler, University of California, Los 
Angeles) or Ccp1p (a kind gift of Dr. Ann English, 
Concordia University, Montreal). Antigen-antibody 
complexes were detected by enhanced chemilumines-
cence using an Amersham ECL Plus Western Blotting 
Detection Reagents (#RPN2132; GE Healthcare). 
Extraction of lipids from purified mitochondria and 
following mass spectrometric identification and 
quantitation of various lipid species were performed 
according to established procedures [37]. The 
“unsaturation index” for each molecular form of 
glycerophospholipids was calculated as previously 
described [72]. For the PA, PG, PS, PE, PC and PI 
species of glycerophospholipids, the unsaturation index 
was calculated as the “glycerophospholipids with one or 
two unsaturated acyl chains (i.e., Cn:1 and Cn:2 
species)/glycerophospholipids without unsaturated acyl 
chains (i.e., Cn:0 species)” ratio. For the MLCL species 
of glycerophospholipids, the unsaturation index was 
calculated as the “glycerophospholipids with one, two 
or three unsaturated acyl chains (i.e., Cn:1, Cn:2 and Cn:3 
species)/glycerophospholipids without unsaturated acyl 
chains (i.e., Cn:0 species)” ratio. For the CL species of 
glycerophospholipids, the unsaturation index was 
calculated as the “glycerophospholipids with one, two, 
three or four unsaturated acyl chains (i.e., Cn:1, Cn:2, Cn:3 
and Cn:4 species)/glycerophospholipids without 
unsaturated acyl chains (i.e., Cn:0 species)” ratio. 
Cellular respiration assay [41], monitoring of the 
mitochondrial membrane potential [41] and ROS 
measurement [94] were performed according to 
established procedures. Preparation of cellular extracts 
and a microanalytic biochemical assay for measuring 
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Figure  S1.  Outline  of  processes  that  define  glycerophospholipid  compositions  of  both  mitochondrial
membranes  in yeast cells. An elaborate network that governs the spatiotemporal dynamics of glycerophospholipids
within mitochondria and  the ER  integrates  the synthesis of some of  their molecular  forms by enzymes confined  to  the
mitochondria‐associated membrane  (MAM)  domain  of  the  ER,  the  synthesis  of  other  glycerophospholipid  species  by




membranes.  See  text  for  details.  Abbreviations:  CDP‐DAG,  cytidine  diphosphate‐diacylglycerol;  MLCL,
monolysocardiolipin; PC, phosphatidylcholine; PG, phosphatidylglycerol; PI, phosphatidylinositol; PS, phosphatidylserine.
  







































www.impactaging.com                    574                                            AGING,  July 2013, Vol. 5 No.7
 





in Methods.  Based  on  these  data,  the  unsaturation  index  for  each molecular  form  of mitochondrial membrane
glycerophospholipids was  calculated as detailed  in Methods. This  index  represents  the  “glycerophospholipids with
one,  two,  three or  four unsaturated  acyl  chains  (i.e., Cn:1, Cn:2, Cn:3  and Cn:4  species)/glycerophospholipids without
unsaturated acyl chains (i.e., Cn:0 species)” ratio. Data are presented as means ± SEM (n = 3; ns, not significant). 
 
